KY HB248 | 2020 | Regular Session

Status

Spectrum: Slight Partisan Bill (Republican 4-2)
Status: Introduced on January 13 2020 - 25% progression, died in committee
Action: 2020-01-15 - to Health and Family Services (H)
Pending: House Health and Family Services Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Create various new sections of KRS Chapter 367 to define terms; to prohibit manufacturers and wholesalers of off-patent or generic prescription drugs from engaging in unrestricted price increases; to require the secretary of the Cabinet for Health and Family Services to report certain price increases to the Attorney General; to establish that certain price increases for off-patent or generic drugs constitute a violation of KRS 367.170; establish penalties.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT relating to prescription drugs.

Sponsors


History

DateChamberAction
2020-01-15Houseto Health and Family Services (H)
2020-01-13Houseintroduced in House

Subjects


Kentucky State Sources


Bill Comments

feedback